Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial

Tuberculosis (TB) associated with diabetes mellitus (DM) is a growing problem, particularly in low- and medium-resource countries. We conducted an open-label, parallel-group, randomized, and controlled trial in a tertiary care center in Mexico City to assess TB preventive treatment (TPT) with isonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamez-Torres, Karla M., Mongua-Rodríguez, Norma, Ferreyra-Reyes, Leticia, Torres-Gonzalez, Pedro, Delgado-Sánchez, Guadalupe, Martínez-Hernández, Maribel, Bobadilla-del-Valle, Miriam, Jasso-Sosa, Velma Y., López-Castillo, Priscila del S., Ferreira-Guerrero, Elizabeth, Cruz-Hervert, Luis Pablo, Sifuentes-Osornio, Jose, Aguilar-Salinas, Carlos A., García-García, Lourdes, Ponce-de-Leon, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459081/
https://www.ncbi.nlm.nih.gov/pubmed/37630477
http://dx.doi.org/10.3390/microorganisms11081917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459081/
https://www.ncbi.nlm.nih.gov/pubmed/37630477
http://dx.doi.org/10.3390/microorganisms11081917

Ejemplares similares